Johnson & Johnson Initiates Global Phase 3 Clinical Trial on 60k Volunteers | NZ Market Update

COVID-19 vaccine Race: Johnson & Johnson Initiates Global Phase 3 Clinical Trial on 60k Volunteers

Johnson & Johnson has initiated a pivotal global Phase 3 clinical study of its COVID-19 vaccine JNJ-78436735.

Janssen’s COVID-19 vaccine candidate uses AdVac® technology platform that projects the vaccine’s stability to remain for two years at a temperature of -20°C and at least three months at 2-8 ° C.

Johnson & Johnson expects the first batches of its COVID-19 vaccine to be accessible for emergency use authorization (EUA) in early 2021

WHS Announces Few Changes in Board

The Warehouse Group Limited (NZX:WHS) founder, Sir Stephen Tindal and the Company’s Deputy Chair, Keith Smith, will retire as directors in November, after working since 1982 and 1988, respectively.

Robbie Tindall has been selected as a director of the Company and will contest for election at the Annual Shareholders’ Meeting. Robbie has worked for the company for eight years in several merchandising and buying roles.

RBD Reports Double-Digit Decline in Profit

For the six months ended 30 June 2020, Restaurant Brands New Zealand Limited (NZX: RBD) reported total group sales of $383.4 million, down by 13.4% on a yo-y basis, mainly led by negative impact of COVID-19 and the reduction in the reporting period by 2 weeks.

Net Profit after Tax for the period stood at $11.4 million or 9.2 cents per share, down by 42.9% on a y-o-y basis;

The company’s total store number now stands at 290, mainly due to the opening of the new Taco Bell stores in New Zealand and Australia.

Comment


Disclaimer

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK